Cargando…

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

Detalles Bibliográficos
Autor principal:	Im, Jong Pil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430004/ https://www.ncbi.nlm.nih.gov/pubmed/28522942 http://dx.doi.org/10.5217/ir.2017.15.2.147

Ejemplares similares

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
por: Lee, Jong Lyul
Publicado: (2019)

Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
por: Hong, Liwen, et al.
Publicado: (2020)

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
por: Gu, Bonita, et al.
Publicado: (2022)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Treatment of Perianal Crohn Disease Fistulae
por: Osterman, Mark T., et al.
Publicado: (2008)

MRI of perianal fistulas in Crohn’s disease
por: Reginelli, Alfonso, et al.
Publicado: (2020)

Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)

Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
por: Jeon, Myunghoon, et al.
Publicado: (2019)

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
por: Yan, Xiaohan, et al.
Publicado: (2019)

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
por: Song, Christine H, et al.
Publicado: (2012)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Risk of Repeat Surgery for Perianal Crohn Disease
por: Lee, Doo Han
Publicado: (2015)

Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
por: Ji, Cheng-Chun, et al.
Publicado: (2017)

Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn’s disease
por: Carlsen, Arne, et al.
Publicado: (2018)

Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study
por: Sirmai, Laura, et al.
Publicado: (2022)

Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study
por: Chun, Jaeyoung, et al.
Publicado: (2018)

Recent developments in the surgical management of perianal fistula for Crohn’s disease
por: Geltzeiler, Cristina B., et al.
Publicado: (2014)

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
por: Reinisch, Walter, et al.
Publicado: (2020)

Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
por: Lee, Jong Lyul, et al.
Publicado: (2021)

A Meta-Analysis of Adalimumab for Fistula in Crohn's Disease
por: Fu, Yin-mei, et al.
Publicado: (2017)

Corrigendum to: Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
Publicado: (2021)

Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review
por: Panes, Julian, et al.
Publicado: (2018)

The Multidisciplinary Management of Perianal Fistulas in Crohn’s Disease: A Systematic Review
por: Badla, Omar, et al.
Publicado: (2022)

Effectiveness of infliximab in the treatment of perianal fistulas in ulcerative colitis: report of two cases
por: de la Piscina, Patricia Ramírez, et al.
Publicado: (2013)

Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2
por: Ruemmele, Frank M, et al.
Publicado: (2018)

Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas
por: Al-Maawali, Alghalya Khalid Sulaiman, et al.
Publicado: (2016)

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease
por: Orts, Beatriz, et al.
Publicado: (2022)

Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
por: Yang, Hua-Hua, et al.
Publicado: (2022)

Comparison of cytokine and phosphoprotein profiles in idiopathic and Crohn’s disease-related perianal fistula
por: Haddow, James B, et al.
Publicado: (2019)

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease
por: Lansdorp, Corine A., et al.
Publicado: (2020)

Mucinous adenocarcinoma in perianal fistula in Crohn's disease: Case report and literature review
por: de Souza, Ana Beatriz Pereira, et al.
Publicado: (2022)

Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab
por: Mizoshita, Tsutomu, et al.
Publicado: (2016)

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
por: Barberio, Brigida, et al.
Publicado: (2020)

Surgical treatment for cryptoglandular and Crohn’s perianal fistulas: Protocol of an umbrella review
por: Mei, Zubing, et al.
Publicado: (2021)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Adalimumab and Infliximab in Crohn’s disease - real life data from a national retrospective cohort study
por: PREDA, C., et al.
Publicado: (2016)

Comparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn’s disease: a systematic review and meta-analysis
por: Gangwani, Manesh Kumar, et al.
Publicado: (2023)

Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
por: Jeong, Seong Yeon, et al.
Publicado: (2014)

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
por: Suzuki, Taketo, et al.
Publicado: (2019)

Management of perianal abscess and fistula-in-ano in infants and children
por: Park, Jinyoung
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h8m0qljta5hqqhsesr8rijmg5n